  See all
 |
Articles: Drug Approvals |
Prior Articles
Bristol-Myers Squibb Announces Acceptance of Submission for Belatacept Biologic License Application
Bristol Myers-Squibb Company, 09/04/09
Free full text
FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone
Cell Therapeutics, 09/04/09
Free full text
Acura Pharmaceuticals and King Pharmaceuticals Provide Update on ACUROX® NDA
King Pharmaceuticals, 09/04/09
Free full text
Shire Announces FDA Approval of Once-Daily INTUNIV? (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Shire, 09/04/09 U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey
Pharmacoepidemiology and Drug Safety, 09/02/09 FDA Approves Valcyte (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Roche, 09/02/09
Free full text
Update on FDA Registration of Actemra, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
Chugai Pharmaceutical Co., 09/02/09
Free full text
FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML
Genzyme, 09/02/09
Free full text
Insecticide Movento granted regulatory approval in Australia
BayNews International, 09/01/09
Free full text
Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B for Over-the-Counter Use
Watson Pharmaceuticals, 08/31/09
Free full text
Panel Will Consider Clinical Data Supporting Approval and Labeling
Genzyme, 08/31/09
Free full text
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
American Pharmaceutical Partners, 08/26/09
Free full text
Health Canada Approves Abbott's XIENCE V Drug Eluting Stent
Abbott, 08/25/09 Novartis receives approval in EU for Xolair to treat children age 6 to 11 years suffering from severe persistent allergic asthma
Novartis, 08/25/09
Free full text
Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review Designation for Rifaximin NDA for the Maintenance of Remission of Hepatic Encephalopathy
Salix Pharmaceuticals, 08/25/09
Free full text
FDA grants marketing approval for Lundbeck's Sabril (vigabatrin)
Lundbeck, 08/24/09
Free full text
Warner Chilcott Completes Irish Redomestication
Warner Chilcott, 08/24/09 Merck is Pleased the FDA and CDC Re-affirm the Safety Profile of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant]
Merck & Co., 08/21/09
Free full text
Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement
Bristol Myers-Squibb Company, 08/21/09
Free full text
Dey Issues Advisory
Mylan, 08/21/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
168 Available Pages
|
|
